INTRODUCTION
Both lymphocyte function-associated antigen-1 (LFA-1; CDlla/CD18) and Mac-1 (CDllb/CD18, CR3) are mem bers of the leukocyte-restricted P2 integrins. This group consists of the following three structurally related glyco proteins: LFA-1, Mac-1, and p i 50,95 (CDllc/CD18) [1, 2] , The P2 integrins are heterodimers composed of a unique (X subunit with a molecular mass of 170, 165, and 150 kDa (for LFA-1, Mac-1, and pl50,95 respectively) and a common P subunit of 95 kDa [3] , Whereas LFA-1 is expressed on all leukocytes [4] , Mac-1 is predominantly expressed by cells of the monocytic lineage [4] [5] [6] [7] [8] , In resting granulocytes Mac-1 is stored in peroxidase-negative granules. Upon addition of inflamma tory mediators degranulation occurs, leading to an in creased surface expression of Mac-1 molecules [8] [9] [10] [11] . In addition, intracellular signals can activate ¡J2 integrins at the cell surface, which can be mimicked by Mn24* [12, 13] or by stimulating antibodies, that activate P2 integrin mole cules by altering the molecular conformation [14] [15] [16] [17] , LFA-1 is involved in distinct adhesion-dependent func tions such as T cell-mediated killing, T helper cell and B I cell responses, natural killer cell activity, monocyte-medi ated antibody-dependent cytotoxicity, and leukocyte adhe sion to endothelial cells [18, 19] . Mac-1 acts as a complement receptor but also mediates phagocytosis by activated macrophages and plays a role in adherence-dependent locomotion of neutrophils in the presence of chemoattractants [7, [20] [21] [22] .
Intercellular adhesion molecule-1 (ICAM-1) is a cellsurface glycoprotein of 90-110 kDa and belongs to the immunoglobulin superfamily [23, 24] . It consists of five immunoglobulin-like domains [24] . Both human LFA-1 and Mac-1 have been described to bind ICAM-1 (CD54) [25] [26] [27] [28] . LFA-1 binds to the first immunoglobulin (Ig)-like domain of ICAM-1 [29, 30] , whereas Mac-1 binds to a distinct site on the ICAM-1 molecule, the third Ig-like domain [30] . ICAM-1 is expressed on a wide range of hematopoietic and non-hematopoietic cells. Expression on unstimulated endothelial cells is low, but lipopolysaccharide, interleukin-1, and tumor n e c r o s is factor-O t rapidly up-regulate both mRNA and surface expression of ICAM-1
[31-33],
Apart from ICAM-1, other ligands for LFA-1 and Mac-1 have been described. LFA-1 can mediate cell adhesion by binding to ICAM-2 [34] or ICAM-3 [35] [36] [37] [38] . Mac-1 has been reported to function as a receptor for the complement component C3bi [7] , factor X [39] and fibrinogen [40, 41] .
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MATERIALS AND METHODS

Monoclonal antibodies
The following monoclonal antibodies (mAb) directed against different murine adhesion molecules were used: M17. 4 
Isolation and purification of the antigens by affinity chromatography
Murine Mac-1 and ICAM-1 were purified by lysing 10 X 109 CAS cells, which expressed both Mac-1 and ICAM-1 at high levels. Isolation of the antigens was performed at 4°C. Cells were lysed in lysis buffer contain ing 0.5% Triton X -100, 150 mM NaCl, and 10 mM triethanolamine. All buffers used were supplemented with 1 mM phenyl-inethyl-sulfonylfluoride (PMSF), 2 mM MgCl2, 1 mM CaCl2, and 50 |ltM sodium vanadate.
For isolation of murine ICAM-1, purified Y N l/1.7 mAb was cova lently linked to CNBr-activated sepharose beads (Pharmacia, 5 rng/mL). For isolation of murine Mac-1 purified M l/70.15 mAb was covalently coupled to CNBr-aclivated sepharose beads (5 mg/mL). The affinity columns were sequentially washed with 5 volumes (corresponding to the volume of the column) of elution buffer (containing 1% p-D-octylglucoside, 400 mM NaCl, and 50 mM triethanolamine), pH 11 (1 mL/min) and 5 volumes of equilibration buffer (0.5% Triton X-100, 150 mM NaCl, and 50 mM triethanolamine) at pH 7.8 (1 mL/min). The lysate was pre-cleared by overnight incubation with rat IgG coupled to CNBractivated sepharose beads and loaded onto the column (flow rate = 1 mL/min). After loading, the column was sequentially washed with 5 volumes of the equilibration buffer at pH 7. 
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:"V lysates by centrifugation at 13,000 g. Subsequently, immunoprecipitates were washed extensively in IPB. 
Electrophoresis and autoradiography
SDS-PAGE was carried out on vertical slab gels (5-15% ) according to a modification of the
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RESULTS
Expression of LFA-1 and Mac-1 on distinct macrophage cell lines
To determine the capacily of LFA-1 and Mac-1 to bind ICAM-1, we first investigated the expression level of these different adhesion receptors on three distinct murine macrophage cell lines (298, 293, and CA5). Immunofluo rescence studies showed that all cells express equal levels of the P2 integrins (M18.2). Staining the cells with specific anti-LFA-1 or anti-Mac-1 mAb revealed that both 298 cells and CA5 cells expressed high levels of LFA-1, whereas 293 expressed low levels of LFA-1. In contrast, high Mac-1 expression was only observed on 293 and CA5 cells (Fig. 1) .
These findings were confirmed by immunoprecipitation studies (Fig. 2) . As expected, LFA-1 but not Mac-1 could be precipitated from the 298 cells (Fig. 2, lanes A and B) .
Only minute amounts of LFA-1 could be precipitated from 293 cells, whereas Mac-1 was precipitated in large quan tities (Fig. 2, lanes D and E) . In contrast, equal amounts of LFA-1 and Mac-1 were precipitated from the CAS cells (Fig. 2, lanes G and H) .
Isolation of murine Mac-1 and ICAM-1
To investigate the interaction of Mac-1 with ICAM-1 in the mouse, we isolated both murine ICAM-1 and Mac-1 from the murine macrophage cell line CAS (see MATERIALS AND METHODS). Fractions collected after elution from the ICAM-I (YN1/1.7) and the Mac-1 (Ml/70.15) affinity column were analyzed by SDS-PAGE and silver staining (Fig. 3) . The fractions eluted from the Mac-1 column con tained the complete 0t/(3 complex, with an (X chain of 165 kDa and a (3 chain of 95 kDa (lane A), whereas the ICAM-1 antigen with a mass of 105 kDa was eluled from the ICAM-1 column (lane B). In an ELISA detection system no contamination of LFA-1 in the purified Mac-1 fraction was observed (Table 1 ; OD450 with anti-LFA-1 mAb is < 0.065). The purity of both Mac-1 and ICAM-1 proteins was > 9 5 % . Fig. 4 , A-C) . Pre-incubation of the cells with EDTA resulted in a complete inhibition of adhesion of the different celt lines to ICAM-1, which indi cates that the adhesion to ICAM-1 is integrin dependent (data not shown). Binding was specific, since no binding of control protein collagen type I was observed (< 5%). The adhesion of the cells to ICAM-1 was not further increased upon addition of Mn2+, which is known to stimulate integrin-mediated adhesion. This finding indicates that the integrins expressed by these cells were already in an acti vated state (data not shown). Adhesion of 298 cells to ICAM-1 was completely LFA-1 dependent (Fig. 4, A and D) , which corresponds with the observation that 298 cells express only LFA-1, No block of adhesion was observed when 298 cells were incubated with an anti-Mac-1 (5C6) mAb, or a control mAb (Rl-2) directed against VLA-4. In contrast, 293 cells (Fig. 4 , C and D) adhered predominantly via Mac-1 to ICAM-1 (82% block with the anti-Mac-1 mAb 5C6), which corresponds to the high expression of Mac-1 and a low expression of LFA-1 on these cells. Adhesion of CAS cells, which ex press as much LFA-1 as the 298 cells, and similar levels of Mac-1 as the 293 cells, could only be blocked by anti-LFA-1 mAb (57%) and not by anti-Mac-1 mAb alone (Fig.  4, B and D) . A small Mac-1-dependent component of 14% was only observed when anti-Mac-1 and anti-LFA-1 mAb were combined (Fig. 4, B and D) . The inability of Mac-1 to bind ICAM-1 was not caused by a defective or inactive form of Mac-1 expressed by CA5 cells, since CAS cells showed strong M ac-l-m ediated adhesion to fibrinogen (Fig. 5A) and BSA (Fig. SB) , two other ligands of Mac-1. are equally expressed on the cell surface, LFA-1 domi-ICAM-1-mediated adhesion to murine Mac-1 nates over Mac-1 for binding ICAM-1 (Fig. 4D) .
To demonstrate that adhesion was specifically mediated To demonstrate that the lack of Mac-l-mediated ICAM-1 by ICAM-1, we blocked the interaction of the distinct cell binding by CAS cells is not due to expression of an inactive lines using Fab fragments of the anti-ICAM-1 mAb form of Mac-1 by these cells, we isolated Mac-1 protein YN1/1.7, which is known to block the LFA-l/ICAM-1 infrom these cells (Fig. 3) and also tested the capacity of teraction [57] . Fab fragments were used to prevent Fc-mecell-bound ICAM-1 to bind to this purified murine Mac-1 diated binding of the macrophage cells to ICAM-1 (Fig. 4,  E and F) . Anti-ICAM-1 mAb completely blocked the adhe sion of 298 cells to ICAM-1, whereas it partially blocked the adhesion of 293 and CA5 cells to ICAM-1. EDTA protein. Purified murine Mac-1 antigen was functional, since CAS cells that express high levels of murine ICAM-1 readily bound to coated purified Mac-1 antigen (Fig. 6 ).
Due to Fc receptor expression on the murine macrophage completely blocked the interaction of all three cell lines to cell lines, F f a b^ fragments of anti-Mac-1 mAb (5C6) were ICAM-1 (data not shown), indicating that the adhesion was used to inhibit the binding. Partial inhibition (50-60%) of specific for integrins (Fig. 4) .
CA5 cells to Mac-1 was observed, demonstrating that ad- hesion is Mac-1 dependent (maximal inhibition obtained with 5C6-F(ab/)2 is 50%, since F(ab')2 fragments are less efficient than complete IgG [49], As expected, EDTA com pletely abrogated binding, showing that adhesion of CAS cells was integrin mediated (Fig. 6 ).
DISCUSSION
In this study we investigated the interaction of Mac-1 with ICAM-1 in the mouse. The following two major conclusions can be drawn: (1) we have shown that ICAM-1 is a ligand for Mac-1 in the mouse as well; (2) by comparing the Mac-l/ICAM-1 with the LFA-l/ICAM-1 interaction on cells expressing both LFA-1 and Mac-1, we observed that LFA-1 and Mac-1 compete for binding to ICAM-1, and that LFA-1 dominates over Mac-1. Although both 293 and CA5 cells express equal amounts of Mac-1, only 293 cells showed a M ac-l-dependent adhe sion to ICAM-1. The observation that Mac-1 on CAS cells was unable to bind to ICAM-1 was not the result of an inactive Mac-1 receptor, since the same cells showed Macl-dependent adhesion to solid-phase fibrinogen and BSA, two other ligands of Mac-1 (Fig. 5) [40, 41] . These results suggest that when both LFA-1 and Mac-1 are present on the cell surface, ICAM-1 preferentially binds to LFA-1. Furthermore, preliminary data show a cross-species inter action of human Mac-1 with murine ICAM-1 (data not shown). This cross-species interaction of Mac-1 with ICAM-1 is, similar to the LFA-l/ICAM-1 [58], unidirec tional. The cross-species interaction of Mac-1 to murine ICAM-1 was only detected when LFA-1-mediated adhe sion was blocked. This indicates that the preference of ICAM-1 to bind to LFA-1 rather than to Mac-1 also exists across the species barrier (data not shown).
Until now, the mechanism underlying the preference for LFA-l/ICAM-1 interaction is not known. However, the data presented in this article suggest that ligand occupa tion by LFA-1 may result in the generation of intracellular signals that may lead to a selective inactivation of the Mac-1 receptor. We cannot exclude the possibility that a higher affinity of LFA-1 compared with Mac-1 may also account for the preference for LFA-1 to bind ICAM-1. Although this is unlikely, since a lower percentage of LFA-1-expressing cells (in absolute numbers; Fig. 4A ), com pared to M ac-l-expressing cells, bound to ICAM-1 {Fig. 4C). Potential differences in affinity between LFA-1 and Mac-1 for binding ICAM-1 might be measured in a Biacore/surface plasmon resonance setting and more experi ments are required to unravel the precise mechanism that may account for the preference for LFA-l/ICAM-1 interac tion. The notion that integrin receptors are selectively used by a cell to bind ligand is further supported by our pre vious observation that LFA-1 can also dominate over VLA-4 in binding of activated T cells to endothelium. In this particular case ligand binding by p2 integrins seem to down-regulate (3] integrin-mediated adhesion [59] . Similar to ICAM-1, the extracellular matrix components fibronectin and laminin can also bind more than one inte grin [60] , Binding of the same ligand by multiple integrins may be functionally important since attachment of that ligand by different integrins may result in distinct intracel lular signals.
Several reports indicate that glycosylation of ICAM-1 may affect adhesion of Mac-1 to ICAM-1 [30, 61] . It has been shown that, when ICAM-1 transfectants are treated with an deoxymannojirimycin, which disrupts Golgi-associated N-linked carbohydrate addition, adhesion to puri fied Mac-1, but not to LFA-1 is improved. This enhanced adhesion is caused by the accumulation of N-linked oli gosaccharides in a high mannose form [61] . Thus the level and type of N-linked glycosylation on ICAM-1 may con tribute to the regulation of integrin-mediated adhesion: myeloid cells may accumulate if ICAM-1 is relatively de glycosylated, whereas lymphocytes may localize if ICAM-1 is more abundantly glycosylated [30] . In our experiments we can detect both LFA-1 (298)-and Mac-1 (293)-de pendent adhesion to purified ICAM-1, indicating that ICAM-1 is properly glycosylated for both LFA-1 and Mac-1 interactions. Adhesion assays of cells expressing both LFA-1 and Mac-1 to deglycosylated ICAM-1 will deter mine whether this may affect the dominance of LFA-1 over Mac-1 for binding ICAM-1.
Because macrophage cells express high levels of Fc re ceptors on their cell surface, F(ab,)2 fragments of an antiMac-1 mAb (5C6) were used to inhibit adhesion of the macrophage cells to purified Mac-1. Complete IgG of mAb 5C6 efficiently inhibited the interaction of Mac-1 with pu rified ICAM-1 (Fig. 4D, cell line 293, 80% inhibition) . However, binding of ICAM-1-expressing cells to purified Mac-1 was only partially blocked with F(al/)2 fragments of mAb 5C6 (60%), whereas Fab fragments of mAb 5C6 or mAb Ml/70.15 were ineffective. The lower inhibition by F(ab')2 fragments of mAb 5C6 may be due to a somewhat lower affinity of F(ab')2 fragments of mAb 5C6 for Mac-1 [49] . Using the anti-ICAM-1 mAb YN1/1.7, we observed that this mAb was unable to block the Mac-l/ICAM-1 in teraction (Fig. 4E, CAS and 293) , while it strongly inhib ited LFA-l/ICAM-1 interaction (Fig. 4A, 298) . Taking into account the high homology between mouse and human ICAM-1, it is most likely that YN1/1.7 bound to the first domain of ICAM-1 and therefore only inhibited LFA-l-mediated adhesion. Until now no anti-ICAM-1 antibodies have been described that inhibit the Mac-l/ICAM-1 inter action in the mouse. Such mAb would be useful to investi gate the contribution of Mac-l/ICAM-1 in both in vitro as well as in vivo cell-cell interactions in more detail.
We have demonstrated by using purified murine ICAM-1 and Mac-1 as a substrate, that ICAM-1 is a ligand for Mac-1 in the mouse. Furthermore we have shown that LFA-1 competes with Mac-1 for binding to ICAM-1, dem onstrating a preference of ICAM-l/LFA-1 binding, when both adhesion receptors are functionally expressed on the cell surface. The importance of this preference remains to be established in vivo.
